Related Experiment Videos
[Molecule based diagnosis].
Hideyuki Akaza1, Tomohiko Ichikawa, Takashi Tsuruo
1Dept. of Urology, Institute of Clinical Medicine, University of Tsukuba.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|January 31, 2004
Summary
Genomic diagnostics enable personalized cancer treatments, improving efficacy and tolerability. Large-scale genomic studies promise reduced ineffective drug therapies and economic benefits.
Area of Science:
- Oncology
- Genomics
- Translational Medicine
Context:
- Advancements in genomic diagnostics are revolutionizing cancer care.
- Understanding genetic defects and tumor-specific antigens is crucial for targeted therapies.
- Genomic insights into drug resistance aid in patient selection and treatment planning.
Purpose:
- To review the impact of genomic diagnostics on future cancer treatments.
- To highlight the potential of large collaborative genomic projects.
- To discuss the development of predictive models for cancer risk and treatment response.
Summary:
- Genomic diagnostics facilitate tailored cancer treatments, enhancing efficacy and tolerability.
- Identifying genetic targets and understanding resistance mechanisms are key for directed therapies.
- Collaborative research and industry partnerships are essential for translating genomic discoveries into clinical practice.
Impact:
- Improved patient outcomes through more effective and personalized cancer therapies.
- Reduced healthcare costs by minimizing ineffective drug treatments.
- Advancement in cancer prediction, diagnosis, and dose selection through genomic insights.